Author

Julijan Kabiljo

Ludwig Boltzmann Institute Applied DiagnosticsORCID 0000-0002-6778-6648Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andreas TiefenbacheriD· 1 shared Anil Baskan· 1 shared Carlos Uziel Pérez MallaiD· 1 shared Gerda EggeriD· 1 shared Janette Pfneissl· 1 shared Jessica KallaiD· 1 shared Kristina DraganićiD· 1 shared Leonhard MüllaueriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andreas TiefenbacherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular OncologyPeer-reviewedMar 11, 2025

Aggressive KRAS mutations direct TGF-β response towards partial EMT in patient-derived colorectal cancer tumoroids

Theresia Mair, Philip König, Milena Mijović…·Gerda Egger

This study investigates how TGF-β affects colorectal cancer tumoroids, finding that aggressive KRAS mutations lead to partial EMT and increased invasiveness.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky